
Lake Erie College of Osteopathic Medicine director discusses medical cannabis reclassification and training…
Photo: ABC7 WWSB
Federal reclassification of medical cannabis as a Schedule III substance does not immediately change rules for patients in Florida's state-managed medical marijuana program, according to a local academic expert. However, the shifting regulatory landscape is expected to encourage medical research and increase the demand for specialized healthcare training. Lake Erie College of Osteopathic Medicine offers a Master of Science in Medical Cannabinoid Therapeutics program to prepare professionals for these developments.
Read the full story at ABC7 WWSBWhy It Matters
Healthcare providers in Florida face a growing need to understand cannabinoid therapies to safely advise the state's large population of medical marijuana cardholders, even as day-to-day patient rules remain under state control.
Key Facts
- The federal government moved to reclassify medical cannabis as a Schedule III substance.
- Federal reclassification does not immediately alter rules for patients in Florida's state-managed medical marijuana program.
- State-managed medical dispensaries in Florida remain under state control despite federal policy changes.
- The evolving regulatory environment is expected to create new opportunities for medical research on cannabis-based treatments.
- Cannabis-based treatments have been studied for conditions including epilepsy, cancer-related symptoms, and chronic illness complications.
- Lake Erie College of Osteopathic Medicine offers a Master of Science in Medical Cannabinoid Therapeutics program to train healthcare professionals.
- The training program covers the history of medical cannabis, cannabinoid interactions with the body, dosing strategies, business operations, and changing regulations.
